FDA warns of false-negative risk with Curative SARS-CoV-2 test

To reduce the risk of false negative results for COVID-19, the Food and Drug Administration (FDA) issued guidance this week for safely using the Curative SARS-CoV-2 test. The communique stresses the importance of administering the test according to authorized labelling and advice on when additional testing should occur following a negative result. An earlier fact sheet for health care providers has additional information. (FDA guidance, 1/4/21)